322 related articles for article (PubMed ID: 29236977)
1. gene2drug: a computational tool for pathway-based rational drug repositioning.
Napolitano F; Carrella D; Mandriani B; Pisonero-Vaquero S; Sirci F; Medina DL; Brunetti-Pierri N; di Bernardo D
Bioinformatics; 2018 May; 34(9):1498-1505. PubMed ID: 29236977
[TBL] [Abstract][Full Text] [Related]
2. Computational drug repositioning using low-rank matrix approximation and randomized algorithms.
Luo H; Li M; Wang S; Liu Q; Li Y; Wang J
Bioinformatics; 2018 Jun; 34(11):1904-1912. PubMed ID: 29365057
[TBL] [Abstract][Full Text] [Related]
3. ksRepo: a generalized platform for computational drug repositioning.
Brown AS; Kong SW; Kohane IS; Patel CJ
BMC Bioinformatics; 2016 Feb; 17():78. PubMed ID: 26860211
[TBL] [Abstract][Full Text] [Related]
4. Leveraging Big Data to Transform Drug Discovery.
Glicksberg BS; Li L; Chen R; Dudley J; Chen B
Methods Mol Biol; 2019; 1939():91-118. PubMed ID: 30848458
[TBL] [Abstract][Full Text] [Related]
5. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
MartÃnez V; Navarro C; Cano C; Fajardo W; Blanco A
Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
[TBL] [Abstract][Full Text] [Related]
6. iDrug: Integration of drug repositioning and drug-target prediction via cross-network embedding.
Chen H; Cheng F; Li J
PLoS Comput Biol; 2020 Jul; 16(7):e1008040. PubMed ID: 32667925
[TBL] [Abstract][Full Text] [Related]
7. Drug repositioning by integrating target information through a heterogeneous network model.
Wang W; Yang S; Zhang X; Li J
Bioinformatics; 2014 Oct; 30(20):2923-30. PubMed ID: 24974205
[TBL] [Abstract][Full Text] [Related]
8. Computational Drug Repositioning: A Lateral Approach to Traditional Drug Discovery?
Sahu NU; Kharkar PS
Curr Top Med Chem; 2016; 16(19):2069-77. PubMed ID: 26881717
[TBL] [Abstract][Full Text] [Related]
9. gep2pep: a Bioconductor package for the creation and analysis of pathway-based expression profiles.
Napolitano F; Carrella D; Gao X; di Bernardo D
Bioinformatics; 2019 Oct; 36(6):1944-5. PubMed ID: 31647521
[TBL] [Abstract][Full Text] [Related]
10. Open-source chemogenomic data-driven algorithms for predicting drug-target interactions.
Hao M; Bryant SH; Wang Y
Brief Bioinform; 2019 Jul; 20(4):1465-1474. PubMed ID: 29420684
[TBL] [Abstract][Full Text] [Related]
11. deepDR: a network-based deep learning approach to in silico drug repositioning.
Zeng X; Zhu S; Liu X; Zhou Y; Nussinov R; Cheng F
Bioinformatics; 2019 Dec; 35(24):5191-5198. PubMed ID: 31116390
[TBL] [Abstract][Full Text] [Related]
12. Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment.
Nagaraj AB; Wang QQ; Joseph P; Zheng C; Chen Y; Kovalenko O; Singh S; Armstrong A; Resnick K; Zanotti K; Waggoner S; Xu R; DiFeo A
Oncogene; 2018 Jan; 37(3):403-414. PubMed ID: 28967908
[TBL] [Abstract][Full Text] [Related]
13. From drug repositioning to target repositioning: prediction of therapeutic targets using genetically perturbed transcriptomic signatures.
Namba S; Iwata M; Yamanishi Y
Bioinformatics; 2022 Jun; 38(Suppl 1):i68-i76. PubMed ID: 35758779
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
Turanli B; Gulfidan G; Arga KY
OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
[TBL] [Abstract][Full Text] [Related]
15. Implementation of a Pipeline Using Disease-Disease Associations for Computational Drug Repurposing.
Balasundaram P; Kanagavelu R; James N; Maiti S; Veerappapillai S; Karuppaswamy R
Methods Mol Biol; 2019; 1903():129-148. PubMed ID: 30547440
[TBL] [Abstract][Full Text] [Related]
16. Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm.
Luo H; Wang J; Li M; Luo J; Peng X; Wu FX; Pan Y
Bioinformatics; 2016 Sep; 32(17):2664-71. PubMed ID: 27153662
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
Wang Y; Yella J; Jegga AG
Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
[TBL] [Abstract][Full Text] [Related]
18. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
[TBL] [Abstract][Full Text] [Related]
19. Recommendation Techniques for Drug-Target Interaction Prediction and Drug Repositioning.
Alaimo S; Giugno R; Pulvirenti A
Methods Mol Biol; 2016; 1415():441-62. PubMed ID: 27115647
[TBL] [Abstract][Full Text] [Related]
20. NeoDTI: neural integration of neighbor information from a heterogeneous network for discovering new drug-target interactions.
Wan F; Hong L; Xiao A; Jiang T; Zeng J
Bioinformatics; 2019 Jan; 35(1):104-111. PubMed ID: 30561548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]